Serratia marcescens Isolated in 2005 From Clinical Specimens From Patients With Diminished Immunity

Transplantation Proceedings

Volumn 39, Issue 9, 2007, Pages 2879-2882

  Mlynarczyk A ^a   Mlynarczyk G ^a   Pupek, J ^a   Bilewska, A ^a   Kawecki, D ^a   Luczak M ^a   Gozdowska, J ^a   Durlik, M ^a   Paczek, L ^a   Chmura, A ^a   Rowinnski W ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE AMPC; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; ENTEROBACTER INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS; TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICROBIAL SENSITIVITY TESTS; SERRATIA INFECTIONS; SERRATIA MARCESCENS; TRANSPLANTATION;

EID: 36049026881     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.08.046     Document Type: Article

References (19)

1. Su L.H., Ou J.T., Leu H.S., et al. Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. J Clin Microbiol 41 (2003) 4726
2. Kim B.N., Choi S.I., and Ryoo N.H. Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit. J Korean Med Sci 21 (2006) 973
3. Naumiuk L., Baraniak A., Gniadkowski M., et al. Molecular epidemiology of Serratia marcescens in two hospitals in Gdansk, Poland, over a 5-year period. J Clin Microbiol 42 (2004) 3108
4. Park Y.J., Park S.Y., Oh E.J., et al. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn Microbiol Infect Dis 51 (2005) 265
5. Yum J.H., Yong D., Lee K., et al. A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate. Diagn Microbiol Infect Dis 42 (2002) 217
6. Queenan A.M., Shang W., Schreckenberger P., et al. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases. Antimicrob Agents Chemother 50 (2006) 3485
7. Hidri N., Barnaud G., Decre D., et al. Resistance to ceftazydyme is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate. J Antimicrob Chemother 55 (2005) 496
8. Livermore D.M. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8 (1995) 557
9. Raimondi A., Sisto F., and Nikaido H. Mutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome. Antimicrob Agents Chemother 45 (2001) 2331
10. Mammeri H., Poirel L., Bemer P., et al. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate. Antimicrob Agents Chemother 48 (2004) 716
11. Shaw K.J., Rather P.N., Sabatelli F.J., et al. Characterization of the chromosomal aac(6′)-Ic gene from Serratia marcescens. Antimicrob Agents Chemother 36 (1992) 1447
12. Rather P.N., Mierzwa R., Hare R.S., et al. Cloning and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens. Antimicrob Agents Chemother 36 (1992) 2222
13. Centron D., and Roy P.H. Presence of a group II intron in a multiresistant Serratia marcescens strain that harbors three integrons and a novel gene fusion. Antimicrob Agents Chemother 46 (2002) 1402
14. Doi Y., Yokoyama K., Yamane K., et al. Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring high-level resistance to aminoglycosides. Antimicrob Agents Chemother 48 (2004) 491
15. Galimand M, Lambert T, Courvalin P: Emergence and dissemination of a new mechanism of resistance to aminoglycosides in Gram-negative bacteria: 16S rRNA methylation. Euro Surveill 2005 (www.eurosurveillance.org/ew/2005/050127.asp#2)
16. Liou G.F., Yoshizawa S., Courvalin P., et al. Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens. J Mol Biol 359 (2006) 358
17. Kumar A., and Worobec E.A. Cloning, sequencing, and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob Agents Chemother 49 (2005) 1495
18. Weigel L.M., Steward C.D., and Tenover F.C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother 42 (1998) 2661
19. Clinical and Laboratory Standards Institute: Antimicrobial susceptibility testing (M100-S16). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, seventh edition (M7-A7). Performance standards for antimicrobial disc susceptibility test: approved standard, ninth edition (M2-A9). Wayne, Pa: Clinical and Laboratory Standards Institute; 2006